Skip to main content

Pharmaceutical Excipients Market worth $9.7 Billion by 2025

The pharmaceutical excipients market is projected to reach USD 9.7 billion by 2025 from USD 6.9 billion in 2019, at a CAGR of 5.8%.


(BLOGGERS NETWORK) Factors such as the growing pharmaceuticals industry coupled with advancements in functional excipients, rising adoption of orphan drugs, and increasing uptake of biopharmaceuticals, are driving the market for pharmaceutical excipients. The emergence of multifunctional excipients, shifting the focus of pharmaceutical manufacturing to emerging markets, and the growing biosimilars industry also present significant growth opportunities for market players.

By functionality, the fillers and diluents segment is expected to account for the largest share of the 
pharmaceutical excipients market in 2019

The fillers & diluents segment accounted for the largest share of the pharmaceutical excipients market in 2018. This market segment is expected to grow due to the increased use of fillers and diluents in the development and production of solid oral drugs. Oral formulations account for a majority share in the pharmaceutical industry, and as these formulations require fillers and diluents the most, this segment automatically has the majority share of the pharmaceutical excipients market.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=956

By formulation, the oral formulations segment is estimated to account for the largest share of this market in 2019

Based on formulation, the pharmaceutical excipients market is segmented into oral, topical, parenteral, and other formulations. In 2018, oral formulations accounted for a major share of the pharmaceutical excipients market, mainly because oral formulations are the most common route of drug delivery. Owing to the shrinking pipeline of new chemical entities (NCEs), companies are increasingly focusing on developing orally disintegrating tablets (ODTs) and other novel methods of oral drug delivery. There is also a growing trend towards sachet formulations.

The Asia Pacific is expected to be the fastest growing the market in 2019

In 2018, the Asia Pacific region was seen as the fastest growing region in the pharmaceutical excipients market. The ease of doing business in the Asia Pacific region in terms of reduced regulatory stringency, reduced raw material & labor costs, and a higher target market make this region the fastest growing market in 2019.

The key players in the global pharmaceutical excipients market are Ashland (US), BASF (Germany), DuPont (US), Roquette (France), Evonik Industries (Germany), Associated British Foods (UK), Archer Daniels Midland Company (US), Lubrizol (US), and Croda International (UK).

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=956

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Sanjay Gupta
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

This news release was first published @EmailWire:
http://www.emailwire.com/release/1112269-Pharmaceutical-Excipients-Market-worth-97-Billion-by-2025.html

Comments

Popular posts from this blog

NQUBATOR Successfully Hosts PropTech Demo Day Supported by Dubai CommerCity Showcasing the Future of Real Estate

NQUBATOR Successfully Hosts PropTech Demo Day Supported by Dubai CommerCity Showcasing the Future of Real Estate Innovation Dubai, UAE – ( ARAB NEWSWIRE ) – NQUBATOR, supported by Dubai CommerCity, successfully hosted the NQUBATOR PropTech Demo Day on 14 May 2026 in Dubai, bringing together investors, founders, real estate leaders, technology innovators, government stakeholders, and ecosystem partners to explore the future of PropTech and AI-driven infrastructure solutions. The event showcased a curated group of high-potential startups operating across property management, smart infrastructure, artificial intelligence, digital transactions, and real estate technology solutions. The participating startups completed NQUBATOR’s incubation program focused on market readiness, scalability, investor preparation, and strategic growth. The Demo Day created a dynamic platform for founders to present their solu...

The SOUEAST Product Matrix: Accelerating Global Growth in Urban Mobility

   BEIJING, China — ( ARAB NEWSWIRE ) — Currently, global passenger vehicle demand is defined by three major trends: the fundamental need for compact commuters, the rise of mid-to-large multi-seater family cars, and the shift toward low-carbon New Energy Vehicles (NEVs). While internal combustion engine (ICE) vehicles remain the mainstream choice due to their reliability, NEVs are gaining ground in the family travel with energy efficiency and no range anxiety. At the same time, consumer preference for SUVs with striking designs, high-end features, and spacious interiors making versatile multi-seater models a key differentiator. Since its brand refresh in 2024, SOUEAST has focused on the urban mobility, building a product matrix including both ICE and NEV models. From city commutes to weekend getaways and from short excursions to long trips, SOUEAST’s lineup systematically covers the diverse needs of urban dwellers, turning“EASE YOUR LIFE”  philosophy into a tang...

Papio Establishes Qatari Subsidiary to Accelerate Industrial AI-Driven Digital Transformation in the Gulf Region

  Doha, Qatar – ( ARAB NEWSWIRE ) — Following its participation at Web Summit Doha, Papio , a global industrial analytics and AI company, today announced the establishment of its Qatari subsidiary through the Qatar Financial Centre (QFC). The new entity will serve customers across Qatar and the wider Gulf region. This marks a major milestone in Papio's global expansion and underscores its long-term commitment to helping industrial organizations build reliable data foundations and translate digital transformation strategies into practical results—delivering measurable improvements in performance, safety, compliance and efficiency across the region. "Papio ensures that digital initiatives translate into measurable business outcomes, sustainable operations, and long-term resilience," said Steven Jansen, Founder and CEO. "The company's Qatari subsidiary will serve as the regional capability center for industrial AI & analytics. Drawing...